FDA Ban on Yaz and Yasmin?
From 2004 to 2008, over 50 deaths among users of Yaz and Yasmin were reported to the FDA. The causes of death include cardiac rrhythmia, cardiac arrest, intracardiac thrombus (blood clots in the heart), pulmonary embolism (blood clots in the lungs) and stroke.
These deaths occurred in women of child bearing years, including women as young as 17! Additionally, though the FDA agrees that Bayer’s advertisements of Yaz and Yasmin obscured the health risks of the drugs (Yaz Warning Letter PDF), and its manufacturing plants are not even properly producing the drugs (YAZ FDA PDF), there has been no indication that the FDA will issue a complete ban on Yaz and Yasmin from the U.S. Market.
The FDA encourages individuals who have had adverse side effects to any FDA approved medication to report those side effects to them. If you have been injured by taking Yaz or Yasmin and want to report your problems to the FDA, please do so on the FDA’s official website (Source).
ConsumerComp Scroll down to the “MedWatch Reporting” section for options to send your complaint. It’s very important that the FDA is made aware of these issues.